Geoffrey Race - 29 Jul 2022 Form 4 Insider Report for F-star Therapeutics, Inc.

Role: Director
Signature: /s/ Darlene Deptula-Hicks, Attorney-in-fact
Issuer symbol: N/A
Transactions as of: 29 Jul 2022
Net transactions value: +$433
Form type: 4
Filing time: 09 Jan 2023, 15:04:38 UTC
Previous filing: 22 Jun 2022
Next filing: 09 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FSTX	Common Stock	Options Exercise	$433	+3,937		$0.1100^*	3,937	29 Jul 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FSTX	Stock Option (right to buy)	Options Exercise	$0	-3,937	-50%	$0.000000	3,937	29 Jul 2022	Common Stock	3,937	$0.1100	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This Report is reporting the exempt exercise of employee stock options for cash payment thereof and receipt of the resulting shares. No shares were sold incidental to the exercise of these stock options.
F2	This exercise price was originally reported incorrectly as $0.08 per share due to a conversion rate error from Pound Sterling into U.S. Dollars. Using the August 2022 approximate exchange rate of 1.2211, the exercise price in U.S. Dollars would be approximately $0.11 per share.
F3	Shall vest in 12 equal monthly installments so long as he remains a director of the company.